Live financial news intelligence

Track market-moving stories before they get noisy

Real-time pulse of financial headlines curated from 5 premium feeds.

Latest market signal Czech Filtered by asset SDGR

Coverage 173,721 Raw stories ingested 23,215 rewritten in CS_CZ • 0 to rewrite (last 2 days).

Symbols 2,795 Assets with fetched stories

Cryptocurrencies BTC 7,716 ETH 5,053 XRP 3,486 SOL 3,139 HYPE 1,831 USDC 1,655

Stocks NVDA 1,895 SPCX 1,494 MU 1,413 MSFT 1,366 AAPL 1,197 AMZN 1,102

Commodities GOLD 567 SILVER 303 OIL 108 PLATINUM 14 PALLADIUM 4 COPPER 3

Forex EURUSD 518 GBPUSD 391 USDCAD 157 USDJPY 152 AUDUSD 101 EURJPY 63

2,203 with rewritten stories in CS_CZ • Hot assets ranked by fetched stories.

Agents 7 waiting Pipeline agents

FMP Stock News Fetch every minute 41s ago
FMP Forex News Fetch every 5 min 3m ago
CoinGecko News Fetch every 5 min 1m ago
FIO Stock News Fetch every 10 min 3m ago
Patria Stock News Fetch every 10 min 3m ago
Editorial rewrite Rewrite every minute 41s ago
Asset sync Assets every 1 hour 43m ago

Latest coverage

Market News Feed

Scan headlines quickly, then expand any story for source context.

Category Source Ticker

Relevance

Clear

Details	Date	Content	Source	Relevance
	Saved 2026-08-31 11:30 14d ago Published 2026-08-29 04:11 16d ago	BlackRock koupil ve společnosti Schrödinger nový 14,25% podíl BlackRock ve 2. čtvrtletí koupil ve společnosti Schrödinger novou pozici a získal 10 521 724 akcií za 170 978 000 USD. K datu podání držel asi 14,25 % firmy. SDGR Schrodinger	FMP Stock News	78
Original source text BlackRock Inc. purchased a new position in Schrodinger, Inc. (NASDAQ:SDGR – Free Report) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 10,521,724 shares of the company’s stock, valued at approximately $170,978,000. BlackRock Inc. owned about 14.25% of Schrodinger as of its most recent filing with the Securities & Exchange Commission. A number of other institutional investors and hedge funds also recently modified their holdings of the stock. EverSource Wealth Advisors LLC lifted its stake in Schrodinger by 722.8% in the 4th quarter. EverSource Wealth Advisors LLC now owns 1,374 shares of the company’s stock worth $25,000 after acquiring an additional 1,207 shares in the last quarter. Los Angeles Capital Management LLC acquired a new stake in Schrodinger in the 4th quarter worth approximately $26,000. Hantz Financial Services Inc. lifted its stake in shares of Schrodinger by 5,025.8% in the fourth quarter. Hantz Financial Services Inc. now owns 1,589 shares of the company’s stock worth $28,000 after buying an additional 1,558 shares during the last quarter. Fideuram Intesa Sanpaolo Private Banking S.P.A. acquired a new position in shares of Schrodinger during the 4th quarter worth about $36,000. Finally, State of Wyoming bought a new stake in Schrodinger in the 2nd quarter valued at $39,000. Institutional investors and hedge funds own 79.05% of the company’s stock. Schrodinger Stock Down 3.5% Shares of SDGR stock opened at $19.70 on Friday. Schrodinger, Inc. has a 12-month low of $10.94 and a 12-month high of $23.02. The firm has a fifty day moving average of $16.89 and a 200-day moving average of $14.15. The company has a market capitalization of $1.45 billion, a price-to-earnings ratio of -26.62 and a beta of 1.63. Schrodinger (NASDAQ:SDGR – Get Free Report) last released its earnings results on Wednesday, August 5th. The company reported $0.08 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.41) by $0.49. Schrodinger had a negative return on equity of 16.37% and a negative net margin of 20.98%.The firm had revenue of $58.89 million during the quarter, compared to analysts’ expectations of $47.19 million. During the same quarter in the prior year, the company earned ($0.65) EPS. The company’s revenue was up 7.5% on a year-over-year basis. On average, equities analysts expect that Schrodinger, Inc. will post -1.89 EPS for the current year. Analyst Ratings Changes SDGR has been the topic of several recent analyst reports. UBS Group assumed coverage on Schrodinger in a research note on Friday, August 14th. They issued a “neutral” rating and a $19.00 price target on the stock. Weiss Ratings raised shares of Schrodinger from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Thursday. Morgan Stanley reduced their target price on shares of Schrodinger from $19.00 to $17.00 and set an “equal weight” rating on the stock in a research note on Thursday, May 14th. Finally, Wall Street Zen raised shares of Schrodinger from a “strong sell” rating to a “hold” rating in a research note on Saturday, August 8th. Three research analysts have rated the stock with a Buy rating, three have given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the company has an average rating of “Hold” and an average target price of $20.50. View Our Latest Analysis on SDGR Schrodinger Company Profile (Free Report) Schrödinger, Inc is a life sciences and materials discovery company that specializes in the application of physics-based computational platforms to accelerate drug discovery and advanced materials design. Founded in 1990 by Professor Richard A. Friesner, Schrödinger has developed a suite of proprietary software tools—such as Maestro for molecular modeling, Glide for molecular docking and Jaguar for quantum chemistry calculations—that enable scientists to predict molecular behavior with high accuracy. Featured Stories Five stocks we like better than Schrodinger 3 Financial Stocks Positioned for the Fed’s Next Move After Jackson Hole IREN’s AI Pivot Looks Real, But the Market Wanted a Faster Payoff After Earnings Boeing’s $131B F-15 Win: Mach 1 Momentum or Just Altitude? Okta Stock Surges 29%—Is $200 the Next Stop? Receive News & Ratings for Schrodinger Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Schrodinger and related companies with MarketBeat.com's FREE daily email newsletter.
	Saved 2026-08-06 03:22 1mo ago Published 2026-08-05 21:36 1mo ago	Schrodinger překonal odhady zisku na akcii i tržeb ve 2. čtvrtletí Schrodinger ve 2. čtvrtletí vykázal zisk 0,08 USD na akcii a tržby 58,89 milionu USD, obojí nad odhady. Tržby meziročně vzrostly z 54,76 milionu USD. SDGR Schrodinger	FMP Stock News	78
Original source text Schrodinger, Inc. (SDGR - Free Report) came out with quarterly earnings of $0.08 per share, beating the Zacks Consensus Estimate of a loss of $0.6 per share. This compares to a loss of $0.59 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of +113.33%. A quarter ago, it was expected that this company would post a loss of $0.56 per share when it actually produced a loss of $0.81, delivering a surprise of -44.64%. Over the last four quarters, the company has surpassed consensus EPS estimates three times. Schrodinger, which belongs to the Zacks Medical Info Systems industry, posted revenues of $58.89 million for the quarter ended June 2026, surpassing the Zacks Consensus Estimate by 15.58%. This compares to year-ago revenues of $54.76 million. The company has topped consensus revenue estimates three times over the last four quarters. The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call. Schrodinger shares have lost about 12.5% since the beginning of the year versus the S&P 500's gain of 13%. What's Next for Schrodinger?While Schrodinger has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock? There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately. Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions. Ahead of this earnings release, the estimate revisions trend for Schrodinger was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is -$0.64 on $51.84 million in revenues for the coming quarter and -$1.89 on $230.28 million in revenues for the current fiscal year. Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Medical Info Systems is currently in the top 30% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1. Another stock from the same industry, Phreesia (PHR - Free Report) , has yet to report results for the quarter ended July 2026. This developer of health care software is expected to post quarterly earnings of $0.11 per share in its upcoming report, which represents a year-over-year change of +1000%. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. Phreesia's revenues are expected to be $129.63 million, up 10.6% from the year-ago quarter.